These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1313320)

  • 21. Lisinopril, a new angiotensin converting enzyme inhibitor.
    Arzubiaga C; Beck NA
    Am J Med Sci; 1992 May; 303(5):340-4. PubMed ID: 1316080
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative trial of lisinopril and nifedipine in mild to severe essential hypertension.
    Mörlin C; Baglivo H; Boeijinga JK; Breckenridge AM; Clement D; Johnston GD; Klein W; Kramer R; Luccioni R; Meurer KA
    J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S49-52. PubMed ID: 2442552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure.
    Paul SD; Kuntz KM; Eagle KA; Weinstein MC
    Arch Intern Med; 1994 May; 154(10):1143-9. PubMed ID: 8185426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and economic effects of replacing enalapril with benazepril in hypertensive patients.
    Briscoe TA; Dearing CJ
    Am J Health Syst Pharm; 1996 Sep; 53(18):2191-3. PubMed ID: 8879328
    [No Abstract]   [Full Text] [Related]  

  • 25. [Multicenter clinical study of the antihypertensive activity of lisinopril].
    Cinotti GA; Bossini A; Cagli V; Corea L; Di Veroli C; Morabito S; Pierucci A; Porcellati C; Savino K; Timio M
    Minerva Med; 1989 Jan; 80(1):53-63. PubMed ID: 2536907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.
    Hayes PC; Plevris JN; Bouchier IA
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():153-8. PubMed ID: 2550638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine.
    McLean AJ; Drummer OH; Smith HJ; Froomes P; McNeil JJ
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():147-51. PubMed ID: 2550637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case report: severe symptomatic hyponatremia associated with lisinopril therapy.
    Subramanian D; Ayus JC
    Am J Med Sci; 1992 Mar; 303(3):177-9. PubMed ID: 1317675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchial hyperreactivity induced by angiotensin converting enzyme inhibitor.
    Goh TC; Ong YY
    Singapore Med J; 1991 Jun; 32(3):183-4. PubMed ID: 1652161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy of lisinopril and nifedipine retard in essential hypertension: a double-blind, placebo-controlled trial.
    Richardson PJ; Meany TB; Johnston GD; Kondowe G; Grimmer SF; Breckenridge AM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S96-8. PubMed ID: 2455154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of lisinopril-induced lithium toxicity.
    Baldwin CM; Safferman AZ
    DICP; 1990 Oct; 24(10):946-7. PubMed ID: 2173864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ambulatory monitoring of arterial pressure in the treatment of mild-moderate arterial hypertension with lisinopril vs. enalapril].
    Motero Carrasco J
    Arch Inst Cardiol Mex; 1997; 67(1):29-37. PubMed ID: 9221708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A 2-year follow-up of lisinopril shows a positive profile concerning adverse effects].
    Lakartidningen; 1991 May; 88(21):1999. PubMed ID: 1647475
    [No Abstract]   [Full Text] [Related]  

  • 34. Lisinopril in the treatment of hypertension.
    Messerli FH; Kaesser UR
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():17-21. PubMed ID: 2550640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization and drug cost outcomes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system.
    Dunn JD; Cannon E; Mitchell MP; Curtiss FR
    J Manag Care Pharm; 2006 May; 12(4):294-302. PubMed ID: 16792435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double blind comparative study of lisinopril and enalapril in patients with essential hypertension.
    Johnston GD; Banks DC; Davies S; Duffin D; Garnham JC; Nicholls DP; Raj MV; Mansy S; Sloan P; Strouthidis TM
    J Hum Hypertens; 1991 Oct; 5(5):405-10. PubMed ID: 1663163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switching from enalapril to lisinopril.
    Brouard A; Conort O; Oliary J; Terrier JL
    Am J Hosp Pharm; 1991 Dec; 48(12):2605. PubMed ID: 1667565
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the antihypertensive effect of lisinopril compared with nifedipine in patients with mild to severe essential hypertension.
    Eber B; Brussee H; Rotman B; Kramer R; Klein W
    Angiology; 1992 Jun; 43(6):482-9. PubMed ID: 1317687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of single doses of lisinopril and enalapril in hypertension.
    Dews I; Wiseman WT; al-Khawaja I; Stephens J; VandenBurg M
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():35-9. PubMed ID: 2550644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring.
    Herpin D; Conte D
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():11-5. PubMed ID: 2550634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.